136 related articles for article (PubMed ID: 19579161)
1. International society for the study of xenobiotics - 11th European meeting.
Cali JJ
IDrugs; 2009 Jul; 12(7):424-7. PubMed ID: 19579161
[No Abstract] [Full Text] [Related]
2. 11th European Regional ISSX Meeting, May 17-20, 2009. Abstracts.
Drug Metab Rev; 2009 May; 41 Suppl 1():1-95. PubMed ID: 19514956
[No Abstract] [Full Text] [Related]
3. Abstracts from the 14th North American ISSX (International Society for the Study of Xenobiotics)Meeting, October 22-26, 2006, Rio Grande, Puerto Rico, USA.
Drug Metab Rev; 2006; 38 Suppl 2():1-258. PubMed ID: 17378085
[No Abstract] [Full Text] [Related]
4. Biotransformation of Drugs and other Xenobiotics as Key Modulator of Toxicity.
Orhan H
Curr Drug Metab; 2021; 22(8):582-583. PubMed ID: 34636292
[No Abstract] [Full Text] [Related]
5. [The biochemical basis of toxic actions of drugs and other xenobiotics].
Nuhn P
Pharm Unserer Zeit; 1993 Jul; 22(3):119-33. PubMed ID: 8367516
[No Abstract] [Full Text] [Related]
6. Reactions and enzymes in the metabolism of drugs and other xenobiotics.
Testa B; Pedretti A; Vistoli G
Drug Discov Today; 2012 Jun; 17(11-12):549-60. PubMed ID: 22305937
[TBL] [Abstract][Full Text] [Related]
7. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data.
Nicholson JK; Lindon JC; Holmes E
Xenobiotica; 1999 Nov; 29(11):1181-9. PubMed ID: 10598751
[No Abstract] [Full Text] [Related]
8. New challenges in kidney cancer therapy: bevacizumab.
Ravaud A
Ann Oncol; 2007 Jul; 18 Suppl 9():ix89. PubMed ID: 17631602
[No Abstract] [Full Text] [Related]
9. Dosing-Time Makes the Poison: Circadian Regulation and Pharmacotherapy.
Dallmann R; Okyar A; Lévi F
Trends Mol Med; 2016 May; 22(5):430-445. PubMed ID: 27066876
[TBL] [Abstract][Full Text] [Related]
10. Abstracts from the 2005 European ISSX Meeting at the Phamscifair, June 12-17, 2005, Nice, France.
Drug Metab Rev; 2005; 37 Suppl 1():1-81. PubMed ID: 16194902
[No Abstract] [Full Text] [Related]
11. Abstracts from the 8th European ISSX Meeting. April 27-May 1, 2003. Dijon, France.
Drug Metab Rev; 2003; 35 Suppl 1():1-168. PubMed ID: 12722745
[No Abstract] [Full Text] [Related]
12. Abstracts from the 7th International ISSX Meeting. August 29-September 2, 2004. Vancouver, Canada.
Drug Metab Rev; 2004 Aug; 36 Suppl 1():1-389. PubMed ID: 15452969
[No Abstract] [Full Text] [Related]
13. Abstracts from the 9th European ISSX Meeting, June 4-7, 2006, Manchester, United Kingdom.
Drug Metab Rev; 2006; 38 Suppl 1():1-187. PubMed ID: 16753951
[No Abstract] [Full Text] [Related]
14. DMW/ISSX 2000 Meeting. The Drug Metabolism Workshop/International Society for the Study of Xenobiotics. St. Andrews, Scotland, June 11-16, 2000. Abstracts.
Drug Metab Rev; 2000; 32 Suppl 1():1-136. PubMed ID: 10909680
[No Abstract] [Full Text] [Related]
15. Monoclonal antibodies in drug targeting.
Panchagnula R; Dey CS
J Clin Pharm Ther; 1997 Feb; 22(1):7-19. PubMed ID: 9292397
[TBL] [Abstract][Full Text] [Related]
16. Arylamine N-acetyltransferases and drug response.
Meisel P
Pharmacogenomics; 2002 May; 3(3):349-66. PubMed ID: 12052143
[TBL] [Abstract][Full Text] [Related]
17. Abstracts from the 6th International ISSX Meeting. October 7-11, 2001. Munich, Germany.
Drug Metab Rev; 2001; 33 Suppl 1():1-274. PubMed ID: 11603370
[No Abstract] [Full Text] [Related]
18. The conduct of initial drug studies in man.
Dollery CT; Davies DS
Br Med Bull; 1970 Sep; 26(3):233-6. PubMed ID: 4922458
[No Abstract] [Full Text] [Related]
19. Abstracts of the 12th North American ISSX Meeting. October 12-16, 2003. Providence, Rhode Island, USA.
Drug Metab Rev; 2003; 35 Suppl 2():1-255. PubMed ID: 14601621
[No Abstract] [Full Text] [Related]
20. Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality.
Carpenter JF; Randolph TW; Jiskoot W; Crommelin DJ; Middaugh CR; Winter G; Fan YX; Kirshner S; Verthelyi D; Kozlowski S; Clouse KA; Swann PG; Rosenberg A; Cherney B
J Pharm Sci; 2009 Apr; 98(4):1201-5. PubMed ID: 18704929
[No Abstract] [Full Text] [Related]
[Next] [New Search]
